28 November 2014

Histone Mutations as a Driver in the Development of Rare Bone Tumours

Organised by:

SCI's Biotechnology Group in conjunction with the University of Westminster

University of Westminster

Registration Closed

This event is no longer available for registration.

Synopsis
Chrondoblastoma (CB) and giant cell tumour of bone (GCT) are rare benign bone tumours that rarely metastasize (around 2% of GCT metastasize to the lung) but very often locally recur. These tumours can be sometimes difficult to distinguish from malignant bone tumours. Recently we identified highly specific mutation in two histone genes H3F3A and H3F3B located on two different chromosomes (chr1 and chr17 respectively) but coding for a very similar protein in those tumours. Ninety-five per cent of CB were found to be mutated in H3F3A as residue G34 (Behjati S, Tarpey P, Presneau N et al., 2013). We have recently investigated a larger set of giant cell tumours and several morphologic mimics including aneurysmal bone cysts, non-ossifying fibromas, giant cell granulomas of the jaws and of small tubular bones as well as giant cell-rich malignant tumours to evaluate the sensitivity and specificity of these H3F3 driver mutations.
Venue and Contact

University of Westminster

University of Westminster, School of Life Sciences, 115 New Cavendish Street London W1W 6UW

 

SCI Communications

Tel: 0207 598 1594

Email: Communications@soci.org


Fees

This is a free event, no need to book. Please check this page for any updates or changes before attending the event

Become an SCI Member and save on this and future events

See Membership Options

Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations


Booking Process

Read our event booking terms and conditions